©2022 Stanford Medicine
Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma
Not Recruiting
Trial ID: NCT01898403
Purpose
This clinical trial compares and contrasts lymph node mapping using indocyanine green
(IC-GREEN), isosulfan blue (ISB), and TSC and Lymphoscintigraphy with 99-technetium (99Tc)
sulfur colloid (TSC).
Study participants with malignant melanoma will undergo all 3 evaluations to assess the
extent of the spread of the melanoma.
Official Title
Testing the Efficacy of Indocyanine Green Imaging (ICG-SPY) in the Identification of Sentinel Lymph Nodes (SLN) in Patients With Malignant Melanoma
Eligibility
Inclusion Criteria:
- Ability to understand and willingness to sign informed consent document
- Signed written informed consent
- Malignant melanoma (MM) undergoing sentinel lymph node biopsy (SNLB)
- 18 years of age or older
- Complete blood count (CBC) and metabolic panel within 6 months
Exclusion Criteria:
- History of hepatic or renal failure
- Allergy to iodine containing products
- Pregnant or may be pregnant
- Psychiatric or addictive disorders that in the opinion of the research team, may not
be able to meet study requirements
- Undergoing dialysis
Intervention(s):
drug: Isosulfan blue (ISB)
diagnostic test: Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC)
drug: indocyanine green solution
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Ralph S. Greco
650-736-1355